| |
KOMISJA NADZORU FINANSOWEGO |
|
| |
|
|
Raport bieżący nr |
3 |
/ |
2023 |
|
|
|
| |
Data sporządzenia: |
2023-03-10 |
|
|
|
|
|
|
|
|
|
| |
Skrócona nazwa emitenta |
|
|
|
|
|
|
|
|
|
| |
MILESTONE MEDICAL |
|
| |
Temat |
|
|
|
|
|
|
|
|
|
|
| |
Commencing sales of CompuFlo Epidural disposables within three Colorado pain management
clinics
|
|
| |
Podstawa prawna |
|
|
|
|
|
|
|
|
| |
Art. 17 ust. 1 MAR - informacje poufne.
|
|
| |
Treść raportu: |
|
|
|
|
|
|
|
|
|
| |
The Board of Directors of Milestone Medical Inc. _WAR: MMD, "the Company", "the Issuer"_,
today announced that it has commenced sales of CompuFlo Epidural disposables across
three pain management clinics in Colorado: Spine Correction Center of the Rockies;
Colorado Clinic; and Colorado Accident and Injury. Adoption of the technology by these
clinics follows a successful evaluation process by Dr. Brad Sisson, MD, a recognized
pain management doctor. Dr. Sisson initially conducted five cases using the CompuFlo
Epidural instrument, in which he reported 100% success. The evaluation included procedures
within the challenging thoracic region of the spine, following the recent FDA approval
of the CompuFlo Epidural System for use in this indication. Dr. Sisson has practiced
pain management in Colorado since 1998 and performed over 15,000 epidural procedures
during his career.
The Board of Directors of the Company is pleased to witness the adoption of our technology
by another three pain management clinics following a successful evaluation period
and looks forward to expanding the nationwide footprint of CompuFlo Epidural system
within pain clinics across the U.S.
|
|
|